WHO good manufacturing practices for pharmaceutical products containing hazardous substances

TRADELABOR has more than 20 years of experience in the control and treatment of air, working with an experienced and qualified technical staff and with the most advanced technology in this area, which together guarantee the quality of the services provided.

 

 

Not all products containing hazardous substances are equally potent and risk assessments should be carried out to determine the potential hazards to operators and to the environment. The risk assessment should also determine which phases of the product production and control cycles,
from manufacture of the API to distribution of the fi nished product, would fall under the requirements of these guidelines. Risk assessments applicable to the environment should include airborne contamination as well as liquid effl uent contamination.

Download PDF File

 

Continue at:  https://www.who.int/medicines/areas/quality_safety/quality_assurance/GMPPharmaceuticalProductsCcontainingHhazardousSubstancesTRS957Annex3.pdf?ua=1

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

www.manostaxx.com

 

Manostaxx
Manostaxx – Industrial Management Consulting

Leave a Reply

Your email address will not be published. Required fields are marked *